Xencor (XNCR) Consolidated Net Income (2013 - 2026)

Xencor (XNCR) reported Consolidated Net Income of -$128.9 million for Q1 2026, down 164.9% year-over-year from $198.6 million in Q1 2025, and down 1832.77% quarter-over-quarter from -$6.7 million in Q4 2025.

Xencor (XNCR) Consolidated Net Income (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Consolidated Net Income data on file, last reported at -$128.9 million in Q1 2026.

  • Consolidated Net Income for Q1 2026 came in at -$128.9 million, down 164.9% year-over-year; the trailing twelve-month figure through Mar 2026 was -$172.4 million (up 18.33% YoY), and the FY2025 annual result was -$92.1 million, up 61.05% from the prior year.
  • Consolidated Net Income declined to -$128.9 million in Q1 2026 per XNCR's latest filing, from -$6.7 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $26.5 million in Q1 2022 and troughed at -$128.9 million in Q1 2026.
  • A 5-year average of -$37.6 million and a median of -$30.8 million in 2025 frame the typical range for Consolidated Net Income.
  • On a YoY basis, Consolidated Net Income climbed as much as 268.87% in 2022 and fell as far as 408.13% in 2022.
  • A 5-year view of Consolidated Net Income shows it stood at -$12.0 million in 2022, then plunged by 118.49% to -$26.3 million in 2023, then plunged by 75.6% to -$46.2 million in 2024, then jumped by 85.56% to -$6.7 million in 2025, then plunged by 1832.77% to -$128.9 million in 2026.
  • Business Quant data shows XNCR's Consolidated Net Income at -$128.9 million in Q1 2026, -$6.7 million in Q4 2025, and -$6.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Xencor 953.38 Mn 878.64 Mn - -128.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -128.92 Mn
Dec 31, 2025 -6.67 Mn
Sep 30, 2025 -6.03 Mn
Jun 30, 2025 -30.78 Mn
Mar 31, 2025 -48.67 Mn
Dec 31, 2024 -46.20 Mn
Sep 30, 2024 -47.44 Mn
Jun 30, 2024 -68.78 Mn
Mar 31, 2024 -74.12 Mn
Dec 31, 2023 -26.31 Mn
Sep 30, 2023 -24.27 Mn
Jun 30, 2023 -26.00 Mn
Mar 31, 2023 -57.85 Mn
Dec 31, 2022 -12.04 Mn
Sep 30, 2022 -32.76 Mn
Jun 30, 2022 -28.00 Mn
Mar 31, 2022 26.47 Mn
Dec 31, 2021 73.06 Mn
Sep 30, 2021 -40.19 Mn
Jun 30, 2021 9.09 Mn